🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Express Worries

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Some experts said the demand for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Service Response and Material Elimination

Based on the social media company, the platform has removed problematic content and banned associated keywords and search suggestions. The company said it was committed to keeping the service secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also found communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

Within moments of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, posts show black plastic packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly significant medical dangers”.